MENLO PARK, Calif. — Healthier Capital has closed its inaugural venture fund at $220 million, exceeding its initial target as investor interest grows in...
AUSTIN, Texas — IntraBio Inc. on Tuesday reported positive topline results from its pivotal Phase III clinical trial evaluating levacetylleucine in pediatric and adult...
BOSTON, Mass. — Roche is significantly expanding its research presence at One Milestone, the flagship life sciences building under construction at Harvard’s Enterprise Research...
RESEARCH TRIANGLE PARK, N.C., and NOTTINGHAM, England — Worldwide Clinical Trials, a global contract research organization, has entered into a definitive agreement to acquire...
NEW HAVEN, Conn. — BioCT, Connecticut’s life sciences trade organization, said it has appointed four senior industry leaders to its Board of Directors, expanding...
MADISON, Wis. — A study published in Nature Communications reports new findings on how cancer cells respond to targeted drugs, identifying a direct connection...
CAMBRIDGE, Mass. — Takeda has announced the U.S. availability of GAMMAGARD LIQUID ERC, a ready-to-use liquid immunoglobulin therapy with low immunoglobulin A content, approved...
Recent Comments